Trial Profile
Randomized Double-Blind Placebo-Controlled Trial of Lubiprostone in the Treatment of Constipation Associated With Parkinson's Disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Lubiprostone (Primary)
- Indications Constipation
- Focus Therapeutic Use
- 09 Jun 2011 Results presented at the 15th International Congress of Parkinson's Disease and Movement Disorders.
- 05 Apr 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov (NCT00908076).
- 05 Apr 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov (NCT00908076).